<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Pathol</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9440</issn>
      <issn pub-type="epub">1525-2191</issn>
      <publisher>
        <publisher-name>American Society for Investigative Pathology</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3123882</article-id>
      <article-id pub-id-type="pmid">21703391</article-id>
      <article-id pub-id-type="publisher-id">AJPA344</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajpath.2011.03.009</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Compartment-Specific Remodeling of Splenic Micro-Architecture during Experimental Visceral Leishmaniasis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yurdakul</surname>
            <given-names>Pinar</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">⁎</xref>
          <xref rid="aff2" ref-type="aff">†</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dalton</surname>
            <given-names>Jane</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Beattie</surname>
            <given-names>Lynette</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brown</surname>
            <given-names>Najmeeyah</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Erguven</surname>
            <given-names>Sibel</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">†</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maroof</surname>
            <given-names>Asher</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kaye</surname>
            <given-names>Paul M.</given-names>
          </name>
          <email>pmk2@york.ac.uk</email>
          <xref rid="aff1" ref-type="aff">⁎</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>⁎</label>Centre for Immunology and Infection, Hull York Medical School and Department of Biology, University of York, York, United Kingdom</aff>
      <aff id="aff2"><label>†</label>Department of Microbiology and Clinical Microbiology, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Address reprint requests to Paul Kaye, Ph.D., Centre for Immunology and Infection, Hull York Medical School, and Department of Biology, University of York, Wentworth Way, York, YO10 5YW, UK <email>pmk2@york.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <month>7</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2011</year>
      </pub-date>
      <volume>179</volume>
      <issue>1</issue>
      <fpage>23</fpage>
      <lpage>29</lpage>
      <history>
        <date date-type="accepted">
          <day>21</day>
          <month>3</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>American Society for Investigative Pathology</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Progressive splenomegaly is a hallmark of visceral leishmaniasis in humans, canids, and rodents. In experimental murine visceral leishmaniasis, splenomegaly is accompanied by pronounced changes in microarchitecture, including expansion of the red pulp vascular system, neovascularization of the white pulp, and remodeling of the stromal cell populations that define the B-cell and T-cell compartments. Here, we show that Ly6C/G<sup>+</sup> (Gr-1<sup>+</sup>) cells, including neutrophils and inflammatory monocytes, accumulate in the splenic red pulp during infection. Cell depletion using monoclonal antibody against either Ly6C/G<sup>+</sup> (Gr-1; RB6) or Ly6G<sup>+</sup> (1A8) cells increased parasite burden. In contrast, depletion of Ly6C/G<sup>+</sup> cells, but not Ly6G<sup>+</sup> cells, halted the progressive remodeling of Meca-32<sup>+</sup> and CD31<sup>+</sup> red pulp vasculature. Strikingly, neither treatment affected white pulp neovascularization or the remodeling of the fibroblastic reticular cell and follicular dendritic cell networks. These findings demonstrate a previously unrecognized compartment-dependent selectivity to the process of splenic vascular remodeling during experimental murine visceral leishmaniasis, attributable to Ly6C<sup>+</sup> inflammatory monocytes.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>Leishmaniasis, caused by protozoan parasites (genus <italic>Leishmania</italic>), is a major neglected disease in resource-poor countries. The species <italic>L. donovani</italic> and <italic>L. infantum</italic> are responsible for visceral leishmaniasis, the most severe form of the disease, which if untreated is almost universally fatal.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> In mouse models, as with human and canine disease, the spleen is the site of chronic infection.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> As infection progresses, marked splenomegaly develops, associated with extensive remodeling of the lymphoid tissue microarchitecture. Elements of the marginal zone are either lost or disrupted in their spatial organization,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> and follicular dendritic cells (FDCs) and fibroblastic reticular cells (FRCs), the key stromal elements that underpin B cell follicle integrity and form the T-cell zone conduit system, respectively,<xref rid="bib4 bib5" ref-type="bibr"><sup>4,5</sup></xref> are progressively denuded.</p>
    <p>More recently, we and others have demonstrated that, in murine experimental visceral leishmaniasis (EVL)<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> and in canine VL,<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> there are pronounced changes to the splenic vasculature that accompany splenomegaly. Notably, in EVL, Meca-32<sup>+</sup> red pulp vessels are greatly enlarged and show signs of angiogenesis. In the white pulp, neovascularization leads to the appearance of numerous CD31<sup>+</sup>αSMA-1<sup>+</sup> vessels that develop coincident with a breakdown in the organization of the FRC and FDC networks.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Studies in wild-type mice treated with neutralizing antibodies and in tumor necrosis factor (TNF)-deficient mice have implicated the proinflammatory cytokine tumor necrosis factor (which is overexpressed by macrophages and many other cells during EVL) as a mediator of white pulp stromal cell remodeling.<xref rid="bib3 bib4" ref-type="bibr"><sup>3,4</sup></xref> However, little is known about the regulation of vascular remodeling within the red pulp or neovascularization in the white pulp.</p>
    <p>Both neutrophils and inflammatory monocytes have recently attracted much interest in the study of leishmaniasis, by acting as a host cells during infection<xref rid="bib8 bib9 bib10" ref-type="bibr"><sup>8-10</sup></xref> and by playing a variety of regulatory roles that affect late stages of both visceral and cutaneous disease.<xref rid="bib10 bib11 bib12" ref-type="bibr"><sup>10–12</sup></xref> More recently, neutrophils that express matrix metalloproteinase 9 (MMP-9),<xref rid="bib13 bib14 bib15" ref-type="bibr"><sup>13–15</sup></xref> as well as inflammatory monocytes,<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> have been implicated in the regulation of angiogenesis in a variety of experimental models of disease. In the context of EVL, however, it is currently unknown whether either cell population plays a role in the splenic tissue remodeling that occurs during progressive disease.</p>
    <p>In the present study, therefore, we sought to determine the effects of depletion of these cells on the progressive changes to splenic architecture that are characteristic of this disease. With use of flow cytometry and confocal microscopy, we show that Ly6C/G<sup>high</sup> neutrophils and Ly6C/G<sup>int</sup> inflammatory monocytes are located within the splenic red pulp and that their number increases during infection. Depletion of either Ly6C/G<sup>int/high</sup> cells [using Gr-1 monoclonal antibody (mAb) RB6] or Ly6G<sup>+</sup> cells (using mAb 1A8) from day 21 to day 28 of infection increased splenic parasite load, but these treatments had distinctly different effects on splenic remodeling. Gr-1 administration led to a selective arrest in red pulp vascular remodeling, whereas neovascularization and the disruption of stromal cell networks in the white pulp continued unabated. In contrast, administration of mAb 1A8 had no effect on any aspect of splenic remodeling that we measured. These data demonstrate for the first time that the regulation of splenic vascular remodeling during EVL occurs in a strictly compartmentalized manner and is independent of mechanisms that control parasite burden.</p>
    <sec sec-type="materials|methods" id="sec1">
      <title>Materials and Methods</title>
      <sec id="sec1.1">
        <title>Mice and Infection</title>
        <p>Female C57BL/6 mice, 6 to 8 weeks old, were obtained from Charles River UK (Margate, UK) and were housed under specific-pathogen-free conditions. <italic>L. donovani</italic> (LV9) amastigotes were obtained from the spleens of infected Syrian hamsters, as described previously.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> Mice were injected with 3 × 10<sup>7</sup> amastigotes i.v. via the lateral tail vein. At day 21 and day 24 after infection, mice were administered 0.2 mg i.p. of Ly6C/G-specific Gr-1 (RB6-8C5) or 0.25 mg Ly6G-specific (1A8) mAbs or their isotype control antibodies (AFRC Mac-5 or Mac-4, respectively). Mice were sacrificed by cervical dislocation at day 28 and spleens were removed for analysis. All experiments were approved by the institutional ethics committee and were performed under U.K. Home Office license.</p>
      </sec>
      <sec id="sec1.2">
        <title>IHC</title>
        <p>Spleen sections (10-μm thick) cut from spleens of both uninfected and infected mice were fixed in ice-cold acetone or 2% paraformaldehyde at room temperature for 15 minutes. Paraformaldehyde-fixed tissue sections were then blocked and permeabilized by 0.1% bovine serum albumin (w/w), 0.1% (v/v) saponin in PBS for 1 hour at room temperature. For MMP-9 localization, sections were double-stained with biotinylated rat anti-MMP-9 (R&amp;D Systems, Minneapolis, MN) and with allophycocyanin-conjugated Gr-1, F4/80, or CD169 (eBioscience, San Diego, CA) primary antibodies, followed by streptavidin Alexa Fluor 488 or streptavidin Alexa Fluor 647. Slides were washed three times with 0.1% (v/v) saponin in PBS. The sections were dehydrated after staining, mounted with antifade solution (Molecular Probes, Eugene, OR), and visualized using a Zeiss Axioplan LSM 510 confocal microscope. For the assessment of vascular changes, sections were stained using biotinylated CD31 (eBioscience) or purified Meca-32 (BD Pharmingen, San Diego, CA) followed by Alexa Fluor 488 streptavidin and fluorescein isothiocyanate goat anti-rat antibody (both from Invitrogen, Carlsbad, CA). Localization of Gr-1<sup>+</sup> and F4/80<sup>+</sup> cells was performed using biotinylated mAb followed by streptavidin conjugated to Alexa Fluor 546 and Alexa Fluor 647 conjugated mAb, respectively. Data were analyzed by quantitative morphometry, as described previously.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref></p>
      </sec>
      <sec id="sec1.3">
        <title><italic>In Situ</italic> Zymography</title>
        <p><italic>In situ</italic> zymography with fluorescein isothiocyanate-labeled dye-quenched gelatin (Enz Chek; Molecular Probes, Eugene, OR) was used to determine the localization of MMP-9 activity in spleen sections. Unfixed sections (8-μm thick) were thawed, preincubated in PBS at room temperature, and incubated with PBS containing 40 μg/mL dye-quenched gelatin (1 mg/mL) in a humidified chamber overnight. At the end of the incubation period, sections were washed three times with PBS and then were dehydrated and mounted with antifade solution. As controls, a general MMP inhibitor, 1,10-phenanthroline (10 mmol/L; Sigma-Aldrich, St. Louis, MO), was added to the PBS/dye-quenched gelatin mixture and applied to frozen cryostat sections. Nonspecific serine protease activity was blocked using phenylmethylsulfonyl fluoride (Sigma-Aldrich). Images were acquired with a Zeiss Axioplan LSM 510 confocal microscope.</p>
      </sec>
      <sec id="sec1.4">
        <title>Flow Cytometry and Intracellular Enzyme Detection</title>
        <p>Splenic cells from naïve or infected mice were homogenized in RPMI and cells were counted on hemocytometer. Then 1 to 2 × 10<sup>6</sup> cells per tube were resuspended in ice-cold PBS buffer consisting of 5 mmol/L EDTA, 1% fetal calf serum, and 1% NaNO<sub>3</sub>. All stainings were performed on ice. Splenic cells were surface stained with phycoerythrin or allophycocyanin conjugated Gr-1, Ly6G-phycoerythrin, Ly6C-fluorescein isothiocyanate, CD11b-Pacific blue, CD11c phycoerythrin-Cy7, and MHCII-allophycocyanin. GR-1 stained cells were washed twice with EDTA/fetal calf serum/NaNO<sub>3</sub>, resuspended in the same buffer, and incubated 15 minutes on ice with 2% paraformaldehyde. Fixed cells were then resuspended in PBS/EDTA/fetal calf serum/NaNO<sub>3</sub> containing 0.5% saponin and intracellularly labeled with biotinylated anti-MMP-9. Biotinylated antibodies were visualized with fluorescein isothiocyanate-streptavidin. Background staining was judged from appropriate isotype control mAbs. Flow cytometric analysis was performed using a CyAn flow cytometry system (Beckman Coulter, High Wycombe, UK) and Summit 4.0 software.</p>
      </sec>
      <sec id="sec1.5">
        <title>Statistical Analysis</title>
        <p>Statistical analysis was performed using a nonpaired Student's <italic>t</italic>-test and two-way analysis of variance. <italic>P</italic> &lt; 0.05 was considered significant. All experiments were repeated independently at least twice.</p>
      </sec>
    </sec>
    <sec id="sec2">
      <title>Results</title>
      <sec id="sec2.1">
        <title>CD11b<sup>+</sup>Ly6C<sup>+</sup> Cells Accumulate in the Spleen During <italic>L. donovani</italic> Infection</title>
        <p>In the spleen of naïve mice, neutrophils can be distinguished from monocytes/DC using a combination of CD11b and Ly6G (<xref rid="fig1" ref-type="fig">Figure 1</xref>A). Within the CD11b<sup>+</sup>Ly6G<sup>−</sup> monocyte/DC population, considerable heterogeneity was found in expression of Ly6C, as has been observed by others.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> During infection with <italic>L. donovani</italic>, the relative balance of neutrophils to monocyte/DC shifts from a ratio of approximately 1:1 to approximately 1:6, reflecting recruitment of inflammatory CD11b<sup>+</sup>Ly6G<sup>−</sup> monocytes/DC cells that are more homogeneous for Ly6C expression (<xref rid="fig1" ref-type="fig">Figure 1</xref>B). By immunohistochemistry (IHC), two populations of Ly6C/G<sup>+</sup> cells were also readily distinguished (<xref rid="fig1" ref-type="fig">Figure 1</xref>, C and D), both localized within the red pulp. Ly6C/G<sup>bright</sup> cells, almost invariably with polymorphonuclear appearance, were found throughout the red pulp in naïve mice (<xref rid="fig1" ref-type="fig">Figure 1</xref>C), whereas most Ly6C/G<sup>dull</sup> cells were concentrated in the subcapsular red pulp and therefore likely represent the resident splenic monocyte pool.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> In contrast, in the spleens of infected mice, large nests of Gr-1<sup>dull</sup> cells could also readily be observed throughout the red pulp (<xref rid="fig1" ref-type="fig">Figure 1</xref>D).</p>
        <p>Previous reports have suggested monocytes, macrophages, and neutrophils as potent cellular sources of proangiogenic MMP-9 during inflammation.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> In the present study, however, IHC analysis, <italic>in situ</italic> zymography, and flow cytometry all revealed that in both naïve mice and infected mice MMP-9 was colocalized almost exclusively with Gr-1<sup>bright</sup> cells, with minimal MMP-9 expression in Gr-1<sup>int</sup> monocytes/DC even after neutrophil depletion (see <xref rid="sec4" ref-type="sec">Supplemental Figure S1</xref> at <ext-link ext-link-type="uri" xlink:href="http://ajp.amjpathol.org"><italic>http://ajp.amjpathol.org</italic></ext-link>).</p>
        <p>To determine the potential role of these two myeloid populations in regulating vascular remodeling during infection, we compared the effects of either depleting both populations (using Gr-1) or just Ly6G<sup>+</sup> neutrophils (using 1A8). Neutrophil depletion was similar in mice treated with either mAb (<xref rid="fig1" ref-type="fig">Figure 1</xref>, E–H), whereas monocytes/DC were depleted only after administration of Gr-1 (<xref rid="fig1" ref-type="fig">Figure 1</xref>, I and J). Immunohistology of 1A8-treated mice showed an almost complete absence of Gr-1<sup>bright</sup> cells, a finding that, together with the flow analysis, helped to confirm that most Gr-1<sup>dull</sup> cells detected by this method were monocytes/DC (<xref rid="fig1" ref-type="fig">Figure 1</xref>K). Consistent with previous studies,<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> administration of Gr-1 mAb during established infection led to an increase in splenic parasite burden: 195 ± 17 versus 304 ± 40 Leishman-Donovan units (LDU) at day 28 after infection in isotype-treated versus Gr-1-treated mice, respectively (<italic>n</italic> = 10 mice; <italic>P</italic> &lt; 0.02). Similarly, administration of 1A8 also increased parasite burden at day 28, from 53 ± 12 LDU to 168 ± 33 LDU (<italic>n</italic> = 7 mice; <italic>P</italic> &lt; 0.001).</p>
      </sec>
      <sec id="sec2.2">
        <title>Ly6C<sup>+</sup> Cells are Selectively Involved in Red Pulp Vascular Remodeling</title>
        <p>To assess the effects of monocyte and neutrophil depletion on splenic vascular remodeling, we performed quantitative IHC on spleen sections from Gr-1 and 1A8 treated mice (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Meca-32 is a pan endothelial marker that recognizes red and white pulp vasculature and the endothelium of the marginal sinus in naïve mice.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> As previously reported,<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Meca-32<sup>+</sup> vessels increased in abundance in the red pulp of mice infected with <italic>L. donovani</italic> (<xref rid="fig2" ref-type="fig">Figure 2</xref>A). Administration of Gr-1 mAb to mice from day 21 to day 28 after infection reduced the level of Meca-32 expression in red pulp to that seen in control uninfected mice (<xref rid="fig2" ref-type="fig">Figure 2</xref>, A and C). In the red pulp, some large-caliber vessels also stained for CD31 (data not shown), and the increase in CD31 in the red pulp observed in infected mice was also arrested after administration of Gr-1 mAb (<xref rid="fig2" ref-type="fig">Figure 2</xref>E). Strikingly, when Ly6G<sup>+</sup> cells alone were depleted using 1A8, no effects were observed on either of these two measures of splenic red pulp vascular remodeling (<xref rid="fig2" ref-type="fig">Figure 2</xref>, A, D, and F). These findings indicate that vascular remodeling in the red pulp is likely to be dependent on the presence of inflammatory Ly6C<sup>+</sup> monocytes/DC.</p>
      </sec>
      <sec id="sec2.3">
        <title>Neither Ly6C/G<sup>+</sup> nor Ly6G<sup>+</sup> Cells Affect Vascular and Stromal Cell Remodeling in the White Pulp</title>
        <p>Remodeling of the white pulp compartment also occurs during EVL.<xref rid="bib6 bib20" ref-type="bibr"><sup>6,20</sup></xref> In the white pulp, CD31 is expressed only on the central arteriole in naïve mice, but with infection it is expressed also in the neovasculature that emerges during progressive infection.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Strikingly, neither administration of Gr-1 or 1A8 mAb had any effect on the neovascularization of the white pulp as measured by CD31<sup>+</sup> vessels (<xref rid="fig2" ref-type="fig">Figure 2</xref>, B, G, and H).</p>
        <p>Loss of the FDC and FRC stromal cell networks is also characteristic of EVL-induced lymphoid tissue remodeling and underpins a loss of T- and B-cell compartmentalization.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> We also assessed, therefore, whether this process was regulated by either Ly6C/G<sup>+</sup> or Ly6G<sup>+</sup> cells. Neither administration of Gr-1 nor 1A8 was able to reverse the disruption seen in T- and B-cell compartments (<xref rid="fig3" ref-type="fig">Figure 3</xref>A). Similarly, loss of FRC networks, measured using gp38 (<xref rid="fig3" ref-type="fig">Figure 3</xref>, B, C, and D), and loss of FDC networks, measured using FDCM1 (<xref rid="fig3" ref-type="fig">Figure 3</xref>, B, E, and F), was equivalent in both Gr-1 and 1A8-treated mice. Thus, by all criteria measured, white pulp remodeling was independent of the presence or absence of neutrophils and monocytes, consistent with the exclusion of these cells from the white pulp.</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Discussion</title>
      <p>The present findings provide a number of new insights into the pathogenesis of EVL-associated splenomegaly. Most importantly, we show that Ly6C<sup>+</sup> inflammatory monocytes/DC located in the red pulp play a major role in remodeling the red pulp vasculature during ongoing splenomegaly. The observation that neither neovascularistion of the white pulp nor white pulp stromal cell networks were affected by monocyte/DC (or neutrophil) depletion suggests strongly that these cells can modify only their immediate environment.</p>
      <p>Our data derived from this model of infection-induced splenic vascular remodeling are in contrast to a number of recent reports that implicated neutrophils as major agents of vascular remodeling: i) neutrophil-derived MMP-9 was able to direct angiogenesis in collagen onplants grafted onto the chorioallantoic membrane of chick embryos,<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> ii) neutrophil depletion caused a significant attenuation of microvessel growth in a model of brain focal angiogenesis induced by AAV-VEGF gene transfer,<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> and iii) neutrophil depletion reduced the number of angiogenic islet dysplasias in RIP1-Tag2 mice.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> However, Gr-1 has often been used as a tool for neutrophil depletion <italic>in vivo</italic> and, as the present findings clearly indicate, the partial loss of monocytes that occurs as a result of Gr-1 administration can have profound functional consequences.</p>
      <p>The present findings add to a growing body of evidence that implicates Ly6C<sup>+</sup>CD11b<sup>+</sup> monocytes/DC/myeloid suppressor cells as regulators of vascular growth and remodeling. For example, such cells are closely associated with the vasculature found in spontaneous prostate cancers in TRAMP mice and produce a range of proangiogenic factors, including MMP-9.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> Gr-1<sup>dull</sup>CD11b<sup>+</sup> cells have been implicated in ischemia-associated neovascularization, with adoptive transfer of these cells improving local blood flow in mice with femoral artery dissection.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> CD11b<sup>+</sup> macrophages have also been implicated in inflammation-induced angiogenesis and lymphangiogenesis in a model of cutaneous leishmaniasis, based on <italic>in vivo</italic> depletion studies using clodronate liposomes.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> Even taking into account variations in phenotypic analysis, differences in methods of <italic>in vivo</italic> depletion, and different endpoints for scoring vascular remodeling, it is difficult to reconcile these data with a single angiogenic stage of monocyte/macrophage/DC differentiation. Rather, it seems likely that the potential for vascular remodeling exists within mononuclear phagocytes at multiple stages of their differentiation, influenced by local environmental factors.</p>
      <p>In both macrophages and neutrophils, MMPs (and MMP-9 in particular) have been implicated as proangiogenic factors,<xref rid="bib13 bib21 bib24" ref-type="bibr"><sup>13,21,24</sup></xref> and human monocytes can be stimulated to produce this metalloproteinase by either alternative IL-4-mediated activation or IL-10-directed deactivation.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> Both cytokines are readily detectable during EVL.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> Taken together, these considerations led us to study the expression of MMP-9 in the spleens of <italic>L. donovani</italic> infected mice. Surprisingly, we were unable to demonstrate MMP-9 expression in any splenic mononuclear phagocyte population, whether by flow cytometry, IHC, or gelatinolytic assays. In neutrophils, however, MMP-9 was abundant. The absence of detectable levels of MM9 in splenic macrophages of mice infected with <italic>L. donovani</italic> would be consistent with the low levels of alternative activation seen in <italic>L. donovani</italic> infection,<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> but may also reflect tissue and/or species-specific differences in MMP-9 expression by macrophages. For example, F4/80<sup>+</sup> peritoneal macrophages expressed significantly more MMP-9 than did neutrophils during the early stages of zymosan-induced peritonitis,<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> consistent with a recent report that peritoneal macrophages infected <italic>in vitro</italic> with <italic>L. chagasi</italic> and cocultured with hepatocytes secrete elevated levels of active MMP-9.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> Similarly, whereas in that study resident peritoneal neutrophils did not express detectable MMP-9,<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> in the present study neutrophils represent the only detectable MMP-9<sup>+</sup> population in the naïve spleen. Although the apparently tight regulation of MMP-9 expression during EVL is of interest, in the present context it appears that MMP-9 is unlikely to play a major role in red pulp vascular remodeling.</p>
      <p>In summary, we have shown that splenic vascular remodeling during EVL takes place in a compartment-specific manner, with red pulp remodeling being regulated directly or indirectly by Ly6C<sup>+</sup> inflammatory monocytes recruited to this site during infection. Although our findings provide an important mechanistic insight into the vascularization process that accompanies splenomegaly, the compartment-specific activity of these monocytes also indicates that some disparate mechanism or mechanisms must be involved in neovascularization of the white pulp.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Further studies are now required to define the cells and factors involved in the latter process.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chappuis</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Sundar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hailu</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ghalib</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rijal</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Peeling</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Alvar</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Boelaert</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?</article-title>
          <source>Nat Rev Microbiol</source>
          <volume>5</volume>
          <year>2007</year>
          <fpage>873</fpage>
          <lpage>882</lpage>
          <pub-id pub-id-type="pmid">17938629</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engwerda</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Ato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis</article-title>
          <source>Trends Parasitol</source>
          <volume>20</volume>
          <year>2004</year>
          <fpage>524</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="pmid">15471704</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engwerda</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Ato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cotterell</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Mynott</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Tschannerl</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gorak-Stolinska</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection</article-title>
          <source>Am J Pathol</source>
          <volume>161</volume>
          <year>2002</year>
          <fpage>429</fpage>
          <lpage>437</lpage>
          <pub-id pub-id-type="pmid">12163368</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stäger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Engwerda</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis</article-title>
          <source>Nat Immunol</source>
          <volume>3</volume>
          <year>2002</year>
          <fpage>1185</fpage>
          <lpage>1191</lpage>
          <pub-id pub-id-type="pmid">12436111</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smelt</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Engwerda</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>McCrossen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Destruction of follicular dendritic cells during chronic visceral leishmaniasis</article-title>
          <source>J Immunol</source>
          <volume>158</volume>
          <year>1997</year>
          <fpage>3813</fpage>
          <lpage>3821</lpage>
          <pub-id pub-id-type="pmid">9103448</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dalton</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Maroof</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Owens</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Narang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Rosenquist</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Beattie</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Coles</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice</article-title>
          <source>J Clin Invest</source>
          <volume>120</volume>
          <year>2010</year>
          <fpage>1204</fpage>
          <lpage>1216</lpage>
          <pub-id pub-id-type="pmid">20234089</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexandre-Pires</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pais</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Correia</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pina</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Leishmaniosis–a report about the microvascular and cellular architecture of the infected spleen in Canis familiaris</article-title>
          <source>Microsc Res Tech</source>
          <volume>69</volume>
          <year>2006</year>
          <fpage>227</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="pmid">16586484</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peters</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Egen</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Secundino</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Debrabant</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kimblin</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kamhawi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lawyer</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Fay</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Germain</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Sacks</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies [Erratum appeared in Science 2008, 322:1634]</article-title>
          <source>Science</source>
          <volume>321</volume>
          <year>2008</year>
          <fpage>970</fpage>
          <lpage>974</lpage>
          <pub-id pub-id-type="pmid">18703742</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thalhofer</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sudan</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Love-Homan</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>M.E.</given-names>
            </name>
          </person-group>
          <article-title>Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi</article-title>
          <source>Infect Immun</source>
          <volume>79</volume>
          <year>2011</year>
          <fpage>108</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">20937764</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Trez</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Magez</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ryffel</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Carlier</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Muraille</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice</article-title>
          <source>PLoS Pathog</source>
          <volume>5</volume>
          <issue>6</issue>
          <year>2009</year>
          <fpage>e1000494</fpage>
          <pub-id pub-id-type="pmid">19557162</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smelt</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Cotterell</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Engwerda</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology</article-title>
          <source>J Immunol</source>
          <volume>164</volume>
          <year>2000</year>
          <fpage>3681</fpage>
          <lpage>3688</lpage>
          <pub-id pub-id-type="pmid">10725726</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tacchini-Cottier</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Zweifel</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Belkaid</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mukankundiye</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Vasei</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Launois</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Milon</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Louis</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major</article-title>
          <source>J Immunol</source>
          <volume>165</volume>
          <year>2000</year>
          <fpage>2628</fpage>
          <lpage>2636</lpage>
          <pub-id pub-id-type="pmid">10946291</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ardi</surname>
              <given-names>V.C.</given-names>
            </name>
            <name>
              <surname>Van den Steen</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Opdenakker</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schweighofer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Deryugina</surname>
              <given-names>E.I.</given-names>
            </name>
            <name>
              <surname>Quigley</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway</article-title>
          <source>J Biol Chem</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>25854</fpage>
          <lpage>25866</lpage>
          <pub-id pub-id-type="pmid">19608737</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jung</surname>
              <given-names>Y.W.</given-names>
            </name>
            <name>
              <surname>Zindl</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Chaplin</surname>
              <given-names>D.D.</given-names>
            </name>
          </person-group>
          <article-title>MMP induced by Gr-1+ cells are crucial for recruitment of Th cells into the airways</article-title>
          <source>Eur J Immunol</source>
          <volume>39</volume>
          <year>2009</year>
          <fpage>2281</fpage>
          <lpage>2292</lpage>
          <pub-id pub-id-type="pmid">19593770</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jablonska</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Leschner</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Westphal</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lienenklaus</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model [Erratum appeared in J Clin Invest 2010, 120:4163]</article-title>
          <source>J Clin Invest</source>
          <volume>120</volume>
          <year>2010</year>
          <fpage>1151</fpage>
          <lpage>1164</lpage>
          <pub-id pub-id-type="pmid">20237412</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horst</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Bickert</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Brewig</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ludewig</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>van Rooijen</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Beauchemin</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>W.D.</given-names>
            </name>
            <name>
              <surname>Fleischer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Wagener</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ritter</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>CEACAM1+ myeloid cells control angiogenesis in inflammation</article-title>
          <source>Blood</source>
          <volume>113</volume>
          <year>2009</year>
          <fpage>6726</fpage>
          <lpage>6736</lpage>
          <pub-id pub-id-type="pmid">19273835</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cotterell</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Engwerda</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani</article-title>
          <source>Infect Immun</source>
          <volume>68</volume>
          <year>2000</year>
          <fpage>1840</fpage>
          <lpage>1848</lpage>
          <pub-id pub-id-type="pmid">10722572</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swirski</surname>
              <given-names>F.K.</given-names>
            </name>
            <name>
              <surname>Nahrendorf</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Etzrodt</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wildgruber</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cortez-Retamozo</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Panizzi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Figueiredo</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Kohler</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Chudnovskiy</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Waterman</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Aikawa</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Mempel</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Libby</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Weissleder</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Pittet</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Identification of splenic reservoir monocytes and their deployment to inflammatory sites</article-title>
          <source>Science</source>
          <volume>325</volume>
          <year>2009</year>
          <fpage>612</fpage>
          <lpage>616</lpage>
          <pub-id pub-id-type="pmid">19644120</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parks</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>López-Boado</surname>
              <given-names>Y.S.</given-names>
            </name>
          </person-group>
          <article-title>Matrix metalloproteinases as modulators of inflammation and innate immunity</article-title>
          <source>Nat Rev Immunol</source>
          <volume>4</volume>
          <year>2004</year>
          <fpage>617</fpage>
          <lpage>629</lpage>
          <pub-id pub-id-type="pmid">15286728</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Maroof</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zubairi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kakiuchi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21</article-title>
          <source>J Immunol</source>
          <volume>176</volume>
          <year>2006</year>
          <fpage>5486</fpage>
          <lpage>5493</lpage>
          <pub-id pub-id-type="pmid">16622017</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ardi</surname>
              <given-names>V.C.</given-names>
            </name>
            <name>
              <surname>Kupriyanova</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Deryugina</surname>
              <given-names>E.I.</given-names>
            </name>
            <name>
              <surname>Quigley</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <volume>104</volume>
          <year>2007</year>
          <fpage>20262</fpage>
          <lpage>20267</lpage>
          <pub-id pub-id-type="pmid">18077379</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hao</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>W.L.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>G.Y.</given-names>
            </name>
          </person-group>
          <article-title>Neutrophil depletion decreases VEGF-induced focal angiogenesis in the mature mouse brain</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <volume>27</volume>
          <year>2007</year>
          <fpage>1853</fpage>
          <lpage>1860</lpage>
          <pub-id pub-id-type="pmid">17392691</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nozawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hanahan</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <volume>103</volume>
          <year>2006</year>
          <fpage>12493</fpage>
          <lpage>12498</lpage>
          <pub-id pub-id-type="pmid">16891410</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dudley</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Udagawa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Melero-Martin</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Shih</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Curatolo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Moses</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Klagsbrun</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors</article-title>
          <source>Blood</source>
          <volume>116</volume>
          <year>2010</year>
          <fpage>3367</fpage>
          <lpage>3371</lpage>
          <pub-id pub-id-type="pmid">20453162</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>March</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Chae</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Johnstone</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Merfeld-Clauss</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Broxmeyer</surname>
              <given-names>H.E.</given-names>
            </name>
          </person-group>
          <article-title>Muscle-derived Gr1(dim)CD11b(+) cells enhance neovascularization in an ischemic hind limb mouse model</article-title>
          <source>Blood</source>
          <volume>1169</volume>
          <year>2010</year>
          <fpage>1623</fpage>
          <lpage>1626</lpage>
          <pub-id pub-id-type="pmid">20516368</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lolmede</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Campana</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Vezzoli</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bosurgi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Tonlorenzi</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Clementi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Bianchi</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Cossu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Manfredi</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Brunelli</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rovere-Querini</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways</article-title>
          <source>J Leukoc Biol</source>
          <volume>85</volume>
          <year>2009</year>
          <fpage>779</fpage>
          <lpage>787</lpage>
          <pub-id pub-id-type="pmid">19197071</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engwerda</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Smelt</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice</article-title>
          <source>Exp Parasitol</source>
          <volume>84</volume>
          <year>1996</year>
          <fpage>195</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">8932769</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hassan</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Engwerda</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Sharp</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bickle</surname>
              <given-names>Q.D.</given-names>
            </name>
          </person-group>
          <article-title>The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani</article-title>
          <source>Am J Pathol</source>
          <volume>169</volume>
          <year>2006</year>
          <fpage>943</fpage>
          <lpage>953</lpage>
          <pub-id pub-id-type="pmid">16936268</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kolaczkowska</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Barteczko</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Plytycz</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Role of lymphocytes in the course of murine zymosan-induced peritonitis</article-title>
          <source>Inflamm Res</source>
          <volume>57</volume>
          <year>2008</year>
          <fpage>272</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">18516709</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Nogueira de Melo</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Vermelho</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Meirelles Mde</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Porrozzi</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>In vitro evidence for metallopeptidase participation in hepatocyte damage induced by Leishmania chagasi-infected macrophages</article-title>
          <source>Acta Trop</source>
          <volume>106</volume>
          <year>2008</year>
          <fpage>175</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="pmid">18433728</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="sec4" sec-type="supplementary-material">
      <title>Supplementary data</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Supplemental Figure S1</title>
            <p>MMP-9 expression in the spleen of naïve and <italic>L. donovani</italic> infected mice. <bold>A</bold> and <bold>B:</bold> Spleen sections, 8 μm thick, from naïve or day 28 infected B6 mice were stained with Gr-1 and for intracellular MMP-9. Nuclei were counterstained with DAPI (blue). MMP-9 (green) was restricted in distribution to Gr-1<sup>bright</sup> cells (red) in the red pulp in both naïve (<bold>A</bold>) and infected (<bold>B</bold>) mice. <bold>C</bold> and <bold>D:</bold> MMP-9<sup>+</sup> cells (green), identified as neutrophils by nuclear morphology, were interspersed with F4/80<sup>+</sup> red pulp macrophages (red) in both naïve (<bold>C</bold>) and infected (<bold>D</bold>) mice. Nuclei are counterstained with DAPI (blue). Scale bar = 20 μm. <bold>E.</bold><italic>In situ</italic> zymography showing strong MMP-9 activity in the red pulp of naïve (left) and infected (right) mice. <bold>F</bold>. Spleen cells from naïve mice (<bold>left</bold> graphs) and day 28 infected mice (<bold>right</bold> graphs) were stained for Gr-1 and intracellular MMP-9 (<bold>upper</bold> graphs) or an isotype control mAb (ISO; <bold>lower</bold> graphs) and examined by flow cytometry. <bold>Oval</bold> gates represent Gr-1<sup>bright</sup> MMP-9<sup>+</sup> cells and show representative frequency. <bold>Rectangular</bold> gates represent Gr-1<sup>dull/neg</sup> cells, including monocytes. <bold>G.</bold> Spleen cells from infected mice treated with isotype control (<bold>left</bold> graphs) or 1A8 (<bold>right</bold> graphs) and stained and gated for Gr-1/ISO and MMP-9/ISO as in F. The percentage of Gr-1<sup>dull</sup> monocytes/DC expressing MMP-9 was 0.4 ± 0.1 in ISO-treated infected mice and was 0.3 ± 0.1 in 1A8-depleted mice.</p>
          </caption>
          <media xlink:href="mmc1.doc" mimetype="application" mime-subtype="msword"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgment</title>
      <p>We thank the staff of the Biological Services Facility at the Department of Biology, University of York, for animal husbandry.</p>
    </ack>
    <fn-group>
      <fn id="d30e282">
        <p>Supported by grants from the Wellcome Trust and the Medical Research Council (P.M.K.). Supported also in part by the Overseas Research Fellowship Program (2214) of the Scientific and Technological Research Council of Turkey.</p>
      </fn>
      <fn id="d30e288">
        <p>P.Y. and J.D. contributed equally to the present work.</p>
        <p>Supplemental material for this article can be found at <ext-link ext-link-type="uri" xlink:href="http://ajp.amjpathol.org"><italic>http://ajp.amjpathol.org</italic></ext-link> or at doi: <ext-link ext-link-type="uri" xlink:href="http://10.1016/j.ajpath.2011.03.009">10.1016/j.ajpath.2011.03.009</ext-link>.</p>
      </fn>
      <fn id="d30e300">
        <p>Current address of A.M., GlaxoSmithKline Biologicals, Hamilton, Montana.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p>Identification of Ly6C/G<sup>+</sup> cells in EVL. Spleens from <italic>L. donovani</italic> infected mice were removed at day 28 after infection and analyzed alongside spleens from naïve mice by flow cytometry and by IHC. <bold>A</bold> and <bold>B:</bold> Spleen cells from naïve (<bold>A</bold>) and infected (<bold>B</bold>) mice were stained with Ly6G and CD11b and the expression of Ly6C was determined on neutrophils (<bold>upper</bold> histograms) and monocytes/DC (<bold>lower</bold> histograms). <bold>C</bold> and <bold>D:</bold> Sections from naïve (<bold>C</bold>) and infected (<bold>D</bold>) mice were stained for Ly6C/G (Gr-1; red) and F4/80 (green) and counterstained with DAPI (blue). Original magnification, ×100. <bold>Insets</bold> show boxed areas at higher magnification: Gr-1<sup>bright</sup> neutrophils (<bold>C</bold>) and a nest of F4/80<sup>−</sup>Gr-1<sup>dull</sup> cells with two neutrophils in close proximity (<bold>D</bold>). Original magnification, ×630. <bold>E:</bold> Spleen cells from infected mice treated with 1A8 or isotype control antibody were stained with Gr-1 and Ly6C. Gr-1<sup>+</sup>Ly6C<sup>+</sup> neutrophils are highlighted in <bold>oval</bold> gated regions. <bold>F:</bold> Spleen cells from infected mice treated with Gr-1 or isotype control antibody were stained with 1A8 and Ly6C. 1A8<sup>+</sup>Ly6C<sup>+</sup> neutrophils are highlighted in <bold>oval</bold> gated regions. <bold>G–J:</bold> Absolute numbers of splenic neutrophils (<bold>G</bold> and <bold>H</bold>) and monocytes/DC (<bold>I</bold> and <bold>J</bold>) in spleens of naïve mice and infected mice were determined using Ly6G (1A8) and Ly6C for Gr-1-depleted mice (<bold>G</bold> and <bold>I</bold>) and using Ly6C and Gr-1 for 1A8-depleted mice (<bold>H</bold> and <bold>J</bold>). Data represent means ± SEM from 7 mice per group, pooled from two independent experiments for Gr-1 depletion and 4 mice per group from one experiment for 1A8 depletion. Similar results were seen in an additional experiment in which 1A8-depleted mice were analyzed using CD11b and Ly6C (data not shown). **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001. ns, not significant. Peripheral blood neutrophils were depleted by 91 ± 4% after 1A8 and 98 ± 0.5% after Gr-1 depletion (data not shown). <bold>K:</bold> Spleen sections from infected mice administered either isotype control (ISO) or 1A8 were stained for Gr-1 (red) and DAPI (blue). Original magnification, ×200.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Figure 2</label>
      <caption>
        <p>Ly6C<sup>+</sup> inflammatory monocytes/DC promote vascular remodeling in the red pulp. Spleens from mice infected with <italic>L. donovani</italic> were removed at day 28 after infection and analyzed alongside spleens from naïve mice by IHC. <bold>A</bold> and <bold>B:</bold> Spleen sections from naïve mice and infected mice treated with isotype control, Gr-1, or 1A8 from day 21 to day 28 after infection were stained with Meca-32 (<bold>A</bold>) or with CD31 (<bold>B</bold>). Original magnification, ×200. <bold>C–H:</bold> Computer-assisted quantitative morphometry was performed to determine the expression of Meca-32 (<bold>C</bold> and <bold>D</bold>) and of CD31 (<bold>E</bold> and <bold>F</bold>) in the red pulp and also the expression of CD31 in the white pulp (<bold>G</bold> and <bold>H</bold>) of mice treated with Gr-1 (<bold>C</bold>, <bold>E</bold>, and <bold>G</bold>) or 1A8 (<bold>D</bold>, <bold>F</bold>, and <bold>H</bold>). Data were generated from multiple sections examined from at least 5 mice per group. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, and ***<italic>P</italic> &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Figure 3</label>
      <caption>
        <p>Neither Ly6C<sup>+</sup> inflammatory monocytes/DC nor Ly6G<sup>+</sup> neutrophils are responsible for white pulp remodeling. Spleens from <italic>L. donovani</italic> infected mice were removed at day 28 after infection and were analyzed, alongside spleens from naïve mice, by IHC. <bold>A</bold> and <bold>B:</bold> Spleen sections from naïve mice and infected mice treated with isotype control, Gr-1, or 1A8 from day 21 to day 28 of infection were stained to identify marginal metallophilic macrophages (CD169; green), B cells (B220; red), and T cells (CD3; blue) (<bold>A</bold>) and FRC (gp38, green) and FDC (FDCM1, red) (<bold>B</bold>). Original magnification, ×200. <bold>C–F:</bold> Computer-assisted quantitative morphometry was performed to determine the expression of gp38 (<bold>C</bold> and <bold>D</bold>) and FDCM1 (<bold>E</bold> and <bold>F</bold>) in mice treated with Gr-1 (<bold>C</bold> and <bold>E</bold>) and 1A8 (<bold>D</bold> and <bold>F</bold>). Data were generated from multiple sections examined from at least 5 mice per group. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
  </floats-group>
</article>